NASDAQ Biotechnology Index (NBI)/ IMU pair, directional comparison.
Divergence between the pair shows IMU now oversold.
Investors have been pulling out of IMU chasing better returns elsewhere.
No appetite for risk on while macro's are as such.
As soon as monetary issues ease funds will return.
A few large individual buys lately could be short covering.
Imugene is in the unique financial position to withstand the downdraft.
imo dyor
IMUGENE CHART. TA only, page-21959
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |